Sensorion Appoints Dr Edwin Moses, Former Ablynx CEO, as Chairman of the Board
(WorldNews France)

Sensorion Appoints Dr Edwin Moses, Former Ablynx CEO, as Chairman of the Board 06 Jul 2020 07:30 CEST Company Name SENSORION ISN FR0012596468 Market Euronext Growth Symbol ALSEN Dr Moses is internationally recognized as a leading CEO and Chairman of life science companies Dr Moses led the rapid growth of Ablynx from a platform technology to a fully integrated biopharmaceutical company prior its acquisition by Sanofi Appointment adds momentum and validation to Sensorion assets and strategy Regulatory News: Sensorion (Paris:ALSEN) (FR0012596468 - ALSEN) a pioneering, clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent...